142 related articles for article (PubMed ID: 19125050)
1. Physical presence during gamma stereotactic radiosurgery.
Sheetz M; Swanson D; Yates B
Health Phys; 2009 Feb; 96(2 Suppl):S11-5. PubMed ID: 19125050
[TBL] [Abstract][Full Text] [Related]
2. NRC inspections: risk-informed and performance-based.
Beardsley MR
J Nucl Med Technol; 2008 Sep; 36(3):129-31; quiz 144. PubMed ID: 18703617
[TBL] [Abstract][Full Text] [Related]
3. Standards for protection against radiation; extension of implementation date--NRC. Final rule.
Fed Regist; 1992 Aug; 57(166):38588-90. PubMed ID: 10121191
[TBL] [Abstract][Full Text] [Related]
4. Web-based training course for evaluating radiological dose assessment in NRC's license termination process.
Lepoire D; Richmond P; Cheng JJ; Kamboj S; Arnish J; Chen SY; Barr C; McKenney C
Health Phys; 2008 Aug; 95 Suppl 2():S137-42. PubMed ID: 18617797
[TBL] [Abstract][Full Text] [Related]
5. Revised standards for protection against radiation; minor amendments--NRC. Final rule: minor corrective and conforming amendments.
Fed Regist; 1992 Dec; 57(236):57877-9. PubMed ID: 10123142
[TBL] [Abstract][Full Text] [Related]
6. Methods and practices used in incident analysis in the Finnish nuclear power industry.
Suksi S
J Hazard Mater; 2004 Jul; 111(1-3):73-9. PubMed ID: 15231350
[TBL] [Abstract][Full Text] [Related]
7. US NRC discussion of options to revise radiation protection recommendations.
Cool DA
Ann ICRP; 2012; 41(3-4):313-7. PubMed ID: 23089031
[TBL] [Abstract][Full Text] [Related]
8. Licensee over-reliance on conservatisms in NRC guidance regarding the release of patients treated with 131I.
Siegel JA; Marcus CS; Stabin MG
Health Phys; 2007 Dec; 93(6):667-77. PubMed ID: 17993847
[TBL] [Abstract][Full Text] [Related]
9. Licensing a new industrial irradiator.
Bates NK; Entwistle FB
Health Phys; 2010 Feb; 98 Suppl 1():S12-6. PubMed ID: 20065665
[TBL] [Abstract][Full Text] [Related]
10. The U.S. NRC and the ADR process learning experiences.
Pérez-Monté JE
Health Phys; 2011 Nov; 101 Suppl 3():S160-3. PubMed ID: 21968823
[TBL] [Abstract][Full Text] [Related]
11. Preparation, transfer for commercial distribution, and use of byproduct material for medical use--NRC. Final rule; clarification.
Fed Regist; 1995 Jan; 60(2 Pt 1):322-5. PubMed ID: 10139994
[TBL] [Abstract][Full Text] [Related]
12. Medical use of byproduct material; policy statement, revision. Nuclear Regulatory Commission. Final policy statement; revision.
Fed Regist; 2000 Aug; 65(150):47654-60. PubMed ID: 11067710
[TBL] [Abstract][Full Text] [Related]
13. A Posting Peculiarity.
Ulsh BA; Bradley E
Health Phys; 2017 May; 112(5):492-493. PubMed ID: 28350706
[TBL] [Abstract][Full Text] [Related]
14. Nuclear medicine technologists and unauthorized self-injections.
Miller KL; King SH; Eggli DF; Thompson LK
Health Phys; 2006 Feb; 90(2 Suppl):S24-8. PubMed ID: 16404185
[TBL] [Abstract][Full Text] [Related]
15. License terms for medical use licenses--NRC. Final rule.
Fed Regist; 1998 Jun; 63(111):31604-7. PubMed ID: 10180132
[TBL] [Abstract][Full Text] [Related]
16. Medical use of byproduct material: issues and request for public input--NRC. Request for public input on rule development.
Fed Regist; 1997 Aug; 62(151):42219-20. PubMed ID: 10169835
[TBL] [Abstract][Full Text] [Related]
17. Revision of fee schedules; 100% fee recovery; clarification of size standards--Nuclear Regulatory Commission. Final rule.
Fed Regist; 1991 Nov; 56(219):57587-8. PubMed ID: 10115559
[TBL] [Abstract][Full Text] [Related]
18. Revision of fee schedules; 100% fee recovery, FY 1992--NRC. Final rule.
Fed Regist; 1992 Jul; 57(142):32691-721. PubMed ID: 10120254
[TBL] [Abstract][Full Text] [Related]
19. Exempt distribution of a radioactive drug containing one microcurie of carbon-14 urea--NRC. Final rule.
Fed Regist; 1997 Dec; 62(231):63634-40. PubMed ID: 10176576
[TBL] [Abstract][Full Text] [Related]
20. License term for medical use licenses--NRC. Proposed rule.
Fed Regist; 1997 Jul; 62(147):40975-8. PubMed ID: 10169830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
